Table 3 Treatment modalities for disseminated intravascular coagulation.
1) Replacement therapy | - Fresh-frozen plasma |
|---|---|
2) Anticoagulants | - Unfractionated and low-molecular-weight heparin |
| Â | - Danaparoid sodium |
| Â | - Recombinant hirudin |
| Â | - Recombinant tissue factor pathway inhibitor |
| Â | - Recombinant nematode anticoagulant protein c2 |
3) Restoration of anticoagulant pathways | - Antithrombin |
| Â | - Recombinant human activated protein C |
4) Other agents | - Recombinant activated factor VII |
| Â | - Antifibrinolytic agents |
| Â | - Antiselectin antibodies |
| Â | - Recombinant interleukin-10 |
| Â | - Monoclonal antibodies against TNF and CD14 |